Delivery Order SPE2DB24D3015-SPE2DB25FFYQN

Award Date 3/24/25
Potential Completion Date 3/25/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,789.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, with a completion date of March 31, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $3,457.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through...
This federal contract award, valued at $1,189.48, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 75 MG TABLET 60S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,318.95 firm fixed-price delivery order is for the supply of BRIVIACT 75 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $1,113.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 100 MG TABLET 60S, a prescription medication, to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical supplier to the U.S. government. The award, valued at $1,705.28, is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to...
This federal contract award, valued at $1,090.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,967.38 firm fixed-price delivery order is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, with a completion date of January 23, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $6,342.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, and has an ultimate completion date of February 7, 2025. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,237.50 firm fixed-price delivery order is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFYQN
    Delivery Order

This federal contract award, valued at $1,889.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of BRIVIACT 75 MG TABLET 60S, a pharmaceutical product, with a final completion date of March 25, 2025.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/29/25, 1:10 AM